Search Results for: stroke

Fact-checking stem cell stroke therapy: hope but not there yet

Stem cell stroke therapy

Stem cell stroke therapy research has generated buzz over the years. The goal of today’s post is to fact-check claims about supposed stem cell stroke therapies and educate readers on where clinical research stands. There is some real hope here in the long run, but things have been greatly exaggerated at times. Some clinics are …

Fact-checking stem cell stroke therapy: hope but not there yet Read More »

Weekend reads: stem cells, CRISPR, glioma, stroke, RTT & more

Venkatesh-et-al.-Nature-2019-Fig-2e

Every so often I realize I’ve accumulated a bunch of tabs on my browsers of things I need to dive into as time permits, which sometimes translates into a collection of recommended reads here on The Niche. Here are some recommended recent reads in the stem cell/regenerative medicine field and childhood cancer space. It includes …

Weekend reads: stem cells, CRISPR, glioma, stroke, RTT & more Read More »

Stroke story stem cell hype analysis: 9 very different headlines

stem-cells-stroke-hype-e1465060807608

I wrote yesterday about two cases of science media hype on CRISPR and on stem cells for strokes. The latter case on stem cell hype stirred the most discussion and even some harsh words in the comments. As this stem cell stroke story on an encouraging but very small, preliminary study has unfolded across the …

Stroke story stem cell hype analysis: 9 very different headlines Read More »

About that Athersys stem cell stroke clinic trial PR…

Athersys

There has been a lot of excitement this week about a press release from stem cell biotech Athersys that reported that treatment of stroke patients with its product MultiStem was associated with a statistically significant improvement at 1-year. This sounds encouraging and the stock has spiked up as a result. However, there are some naysayers …

About that Athersys stem cell stroke clinic trial PR… Read More »

In Bart Starr stem cell treatment for stroke, following Howe to Mexico?

Bart-Starr

NFL Hall of Fame player Bart Starr has reportedly turned to stem cells for hope after having a series of strokes in 2014. The Starr family made a statement that Bart, now 81 years old, was accepted into a clinical trial using stem cells. This seems similar to the stem cell path that the family …

In Bart Starr stem cell treatment for stroke, following Howe to Mexico? Read More »

Multi-Billion Dollar NIH Brain Initiative A Stroke of Genius or Madness?

Tales_serial-192x3001

Is the new multi-billion dollar NIH Brain Initiative a stroke of madness or genius? For some non-brain researchers scrambling for funding from NIH, it could well just give them a stroke. At the same time as the NIH and Obama are asking for $4.5 billion (yes, with a b) for the new “big science” Brain …

Multi-Billion Dollar NIH Brain Initiative A Stroke of Genius or Madness? Read More »

Key Mayo Clinic stem cell webpage is overexuberant & outdated

The Mayo Clinic.

The Mayo Clinic does some great research on stem cells and regenerative medicine. However, at times I’ve felt that a few Mayo researchers are overexuberant. This mainly relates to certain not-yet-proven stem cell and related offerings. Fitting with that perception, the Mayo website also has some inaccurate stem cell content that leans toward overstating things. …

Key Mayo Clinic stem cell webpage is overexuberant & outdated Read More »

Weekly reads: Vertex, stem cells for MS, Athersys, 900-day paper review at Nature

“While still early, these results support the continued progression of our VX-880 clinical studies, as well as future studies using our encapsulated islet cells, which hold the potential to be used without the need for immunosuppression,” said Bastiano Sanna, Ph.D., executive vice president and chief of cell and genetic therapies at Vertex.

Vertex Pharmaceuticals has a lot going for it right now on the cell therapy front. For instance, they have the strongest type 1 diabetes cell therapy pipeline after some recent acquisitions. Still it’s not a simple matter to succeed in the cell therapy space even with one therapy for one targeted disease. Trials are tough …

Weekly reads: Vertex, stem cells for MS, Athersys, 900-day paper review at Nature Read More »

20 stem cell & regenerative medicine predictions for 2024

Stem cell, crystal ball, predictions

Each year I make predictions for the stem cell and regenerative medicine field for the following year. Today’s prediction post is focused on what to expect in 2024. You can also see my stem cell predictions for 2023 and my grades on how I did. I also have made a video version of these predictions so please …

20 stem cell & regenerative medicine predictions for 2024 Read More »